These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 34752810)

  • 21. Effect of Acupuncture on Ovary Morphology and Function in DHEA-Induced Polycystic Ovary Syndrome Model Rats.
    Li D; Bai P; Wu JY; Xie M; Zhao RZ; Wang ZP; Qi XH
    Chin J Integr Med; 2021 Mar; 27(3):220-224. PubMed ID: 33666871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
    J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.
    Çelik LS; Kuyucu Y; Yenilmez ED; Tuli A; Dağlıoğlu K; Mete UÖ
    Ultrastruct Pathol; 2018; 42(1):55-64. PubMed ID: 29192811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
    Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
    Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin.
    Olaniyan OT; Bamidele O; Uche S; Femi A; Ayobami D; Ayoola O; Builders M; Mali PC
    JBRA Assist Reprod; 2020 Jan; 24(1):41-54. PubMed ID: 31608617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles.
    Anderson E; Lee GY; O'Brien K
    Anat Rec; 1997 Sep; 249(1):44-53. PubMed ID: 9294648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
    Priyadarshani A
    J Endocrinol Invest; 2009 Nov; 32(10):837-43. PubMed ID: 19609106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
    Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
    J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome.
    Sarvestani M; Rajabzadeh A; Mazoochi T; Samimi M; Navari M; Moradi F
    BMC Endocr Disord; 2024 Aug; 24(1):154. PubMed ID: 39160512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
    Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
    Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
    Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
    PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoarchitectural differences in reproductive organs of some polycystic ovary-like induced animal models.
    Kadir ER; Yakub AD; Ojulari LS; Hussein AO; Adetayo Lawal I; Jaji-Sulaimon R; Ajao MS
    Tissue Cell; 2024 Aug; 89():102456. PubMed ID: 38991273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
    Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
    Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.
    Elia E; Sander V; Luchetti CG; Solano ME; Di Girolamo G; Gonzalez C; Motta AB
    Mol Hum Reprod; 2006 Aug; 12(8):475-81. PubMed ID: 16809378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
    Chen W; Liao B; Yun C; Zhao M; Pang Y
    J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.